# Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

> **NCT04975932** · — · COMPLETED · sponsor: **Zhongda Hospital** · enrollment: 826 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** TACE+ICIs
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT04975932
- **Lead sponsor:** Zhongda Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2023-02-08
- **Target enrollment:** 826 (ACTUAL)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04975932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04975932, "Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04975932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*